Gella, Ramil S.
HRN: 25-74-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2024
CEFTAZIDIME 1GM (VIAL)
09/01/2024
09/07/2024
IV
2g
Q8h
BA In AE; T/c PTB Relapse
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes